Brian Berman
Dermatology · Aventura, FLNPI 1255316352
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Almirall LLC at 38.9% of the total. Reporting peaked in 2019 at $92,772 and has fallen 54.6% since, to $42,156 in 2025. Among dermatology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 398 payments — averaging $1016.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Almirall LLC$157K
- Novartis$62K
- Sun Pharmaceutical Industries Inc.$50K
- Sensus Healthcare, Inc.$30K
- LEO Pharma Inc.$21K
- Dermira, Inc.$16K
- plus $69K from 30 others
Across 22 payments — averaging $1355.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$14K
- Bristol Myers Squibb$9K
- Pfizer$3K
- VYNE Pharmaceuticals Inc.$3K
- Amgen$1K
What the payments were for
- Consulting fees$240,78360%
- Speaking & faculty fees$123,91931%
- Travel & lodging$23,5296%
- Food & beverage$16,4234%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Almirall LLC | 118 | $157,430 |
| Novartis | 56 | $61,847 |
| Sun Pharmaceutical Industries Inc. | 51 | $50,328 |
| Sensus Healthcare, Inc. | 2 | $29,655 |
| LEO Pharma Inc. | 11 | $20,534 |
| Dermira, Inc. | 23 | $16,292 |
| Pfizer | 8 | $11,724 |
| E.r. Squibb & Sons, L.L.C. | 11 | $7,529 |
| LNHC, Inc | 8 | $7,126 |
| EPI Health, LLC | 13 | $6,805 |
| Regeneron | 9 | $6,584 |
| Journey Medical Corporation | 6 | $6,200 |
| DUSA Pharmaceuticals, Inc. | 6 | $5,887 |
| Aclaris Therapeutics, Inc. | 11 | $5,522 |
| Biofrontera Inc. | 15 | $4,118 |
| Glenmark Pharmaceuticals Limited | 1 | $3,000 |
| Verrica Pharmaceuticals Inc. | 3 | $1,364 |
| Incyte Corporation | 9 | $427 |
| Encore Dermatology Inc. | 4 | $388 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $288 |
| AbbVie | 3 | $249 |
| Bristol Myers Squibb | 2 | $201 |
| Arcutis Biotherapeutics, Inc. | 5 | $188 |
| Galderma Laboratories, L.p. | 4 | $170 |
| Regeneron Healthcare Solutions, Inc. | 5 | $159 |
| Sanofi | 1 | $125 |
| Revance Therapeutics, Inc. | 1 | $121 |
| Dermavant Sciences, Inc. | 1 | $120 |
| Genentech, Inc. | 1 | $80 |
| Amgen | 1 | $50 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Boehringer Ingelheim | 1 | $39 |
| Genentech USA, Inc. | 1 | $27 |
| UCB, Inc. | 1 | $25 |
| AstraZeneca | 1 | $16 |
| Strata Skin Sciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$404,673 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.
Other dermatology in Aventura
- Mark NestorAventura$565K
- Barry ResnikAventura$182K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.